C. Jolles

发表

Dietary Vitamins A, C, and E and Selenium as Risk Factors for Cervical Cancer

T. French, D. West, M. Slattery, 1990, Epidemiology.

Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas.

J. Holden, I. Bronstein, S. Vorobyev, 1997, Molecular pathology : MP.

Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies.

J. Holden, I. Bronstein, S. Vorobyev, 1996, Oncology research.

and in ovarian carcinomas . paraffin wax embedded normal tissues topoisomerase I in formalin fixed , Immunohistochemical detection of DNA

J. Holden, I. Bronstein, S. Vorobyev, 2022 .

Estrogen and progestogen therapy in advanced ovarian cancer: preliminary report.

R. Freedman, L. Jones, C. Jolles, 1983, Gynecologic oncology.

Cisplatin versus carboplatin in advanced ovarian cancer: An economic analysis

D. Alberts, R. O’Toole, E. Hannigan, 1994 .

Advanced ovarian dysgerminoma with cure of tumor persistent in meninges.

D. Smotkin, C. Jolles, S. Karayianis, 1989, Gynecologic oncology.

Immunohistochemical staining for DNA topoisomerase II in frozen and formalin-fixed paraffin-embedded human tissues.

S. Perkins, J. Holden, C. Kjeldsberg, 1994, Modern Pathology.

Pseudomyxoma peritonei associated with secondary infertility.

W. Keye, C. Jolles, H. A. Hales, 1992, Fertility and sterility.

Complications of extended-field therapy for cervical carcinoma without prior surgery.

R. Freedman, C. Jolles, D. Horbelt, 1986, International journal of radiation oncology, biology, physics.

Isolation of maize protoplasts from the root cap and apex.

P. Pilet, C. Jolles, H. Henry, 1985 .

SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES

R. Straight, V. King, D. Lynch, 1989, Photochemistry and photobiology.

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin–cyclophosphamide versus carboplatin–cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study

D. Alberts, S. Green, S. Dahlberg, 2010, Cancer.

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

D. Alberts, R. O’Toole, S. Green, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gynecologic cancer associated with pregnancy.

C. Jolles, 1989, Seminars in oncology.

IAA, ABA Content and Metabolism in Maize Root Protoplasts

P. Pilet, C. Jolles, 1988 .

Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.

W. Sause, D. Gaffney, D. Ly, 2014, Gynecologic oncology.

Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study.

E. Atkinson, R. Freedman, D. Gershenson, 1986, Cancer treatment reports.

GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience.

R. Straight, C. Peterson, D. Carrell, 1994, Gynecologic oncology.